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Dysostosis multiplexAbstract a-Fucosidosis is a rare inherited neuro-degenerative disorder causing progressive neuro-
logical deterioration leading to early death. Definitive diagnosis requires a-fucosidase enzyme assay
or FUCA1 gene testing, which being expensive limits the definitive diagnosis in resource limited
countries. We present two siblings with classic symptoms, radiological and MRI brain findings sug-
gestive of a-fucosidosis and a clinical approach to reach to the diagnosis.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Ain Shams University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
a-Fucosidosis (OMIM # 230000) is an autosomal recessive
lysosomal storage disorder caused by the deficiency of fucosi-
dase enzyme due to mutations in FUCA1 gene [1]. It was first
reported in 1966 [2] and since then less than 120 cases have
been reported [3]. Patients present with broad clinical spectrum
of progressive psychomotor regression, coarse facies, dysosto-
sis multiplex, angio-keratoma, visceromegaly and seizures [4].
The definitive diagnosis of a-fucosidosis is established based
on either the decreased activity of fucosidase enzyme or the
detection of a mutation in FUCA1 gene. Both approaches
are expensive and often limit the definitive diagnosis in coun-
tries with limited resources. We present two siblings witha-fucosidosis from Pakistan, focusing on radiological findings
as a diagnostic tool to develop an approach to a patient with
dysostosis multiplex, in neuro-degenerative disorders including
a-fucosidosis (Fig. 1).
2. Case report
2.1. Patient 1
A 6.5 year old boy, third child of first-cousin parents, was seen
at the metabolic clinic for psychomotor regression noted at
11 months of age. He was born after a full-term, uneventful
pregnancy. The parents reported normal growth and develop-
ment till 11 months of age, after which initial stagnation of
development followed by progressive spasticity of body was
noted. Eventually his ability to sit unsupported and cruise
was lost. Parents also reported progressive deterioration in
his ability to understand and respond socially. Frequent aspi-
ration during feeding was a significant issue. However, no sei-
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Figure 1 Approach to dysostosis multiplex.
244 R. Shaukat et al.zures were reported. At the time of his assessment weight,
height and head circumference was 11 kg, 91 cm and 46.5 cm
respectively (all <5th percentile). He was noted to have no
facial coarsening but a scissoring posture along with hepato-
splenomegaly was noted on physical examination; liver was
5 cms below right coastal margin and spleen 3 cms in the long
axis, (Fig. 2a). He was also noted to have spastic quadraparesis
with increased deep tendon reflexes. However, no corneal
clouding, contractures or cutaneous changes including angiok-
eratoma were noted. Ophthalmologic evaluation did not reveal
cherry red spots. X-ray of the spine showed an anterior break-
ing of lumbar vertebrae, (Fig. 3a). The MRI brain was done,
which showed a significant loss of white matter causing cere-
bral atrophy and enlarging CSF spaces (Fig. 3b).
Based on the clinical features of hepatosplenomegaly,
dysostosis multiplex on X-rays, classical MRI brain fea-
tures along with the absence of facial coarsening and
cherry red spots; our differential diagnosis included
Alpha-fucosidosis, Mucopolysaccharidosis type III & typeIV. In our patients, psychomotor regression and the pres-
ence of organomegaly led us to the diagnose Alpha-
fucosidosis as Psychomotor regression is not a feature of
Mucopolysaccharidosis type IV and organomegaly is not
noted in Mucopolysaccharidosis type III and type IV. To
evaluate for the cause, his urine oligosaccharide analysis
was performed at Institute Medical Research, Kuala Lum-
pur, which showed densely-staining band at the origin and
other distinct bands above it showing pattern similar to
positive control of a-fucosidosis (Fig. 4). Enzyme activity
of a-fucosidase in leukocytes was 1 nmol/h/mg protein
which was less than 1% from normal mean. These two
laboratory methods confirmed the diagnosis.
2.2. Patient 2
Patient 2 was the younger brother of patient 1. He was 3 year
old at the time of evaluation for psychomotor regression,
which started at 12 months of age.
Figure 2 (a: patient 1, b: patient 2): Showing mild facial coarsening, spastic Quadraparesis and scissoring posture.
Figure 3 (a) (Patient 1) shows anterior beaking of thoraco-lumbar spines. (b) (Patient 1; MRI brain T2WI) shows a decrease in the
volume of white matter. (c and d) (Patient 2; MRI brain T2WI) shows hypointense signals in bilateral thalami & substantia nigra.
Alpha-fucosidosis 245He was born after an uneventful full-term pregnancy. The
parents reported normal growth and development till
12 months of age. He had just started cruising when parents
noted progressive spasticity of body limiting his ability to
cruise and eventually he was unable to sit or hold neck and
was unable to follow simple instructions. Unlike his brother,
aspiration during feeds was not reported. At the time of clini-
cal assessment his weight, height and head circumference was
11.4 kg, 87 cm and 42 cm respectively (all <5th percentile).
Physical examination revealed scissoring posture and hep-
atosplenomegaly (Liver of 4 cms below right coastal margin
and spleen of 3 cms in the long axis). Fig. 2b. He was also
noted to have spastic quadraparesis with increased deep ten-
don reflexes. No corneal clouding, contractures or cutaneous
changes and facial coarsening were noted. Cherry red spots
were not noted on ophthalmological examination. X-ray spineshowed an anterior breaking of lumbar vertebrae. The MRI
brain showed hypo-intense signals in bilateral thalami and sub-
stantia nigra. Fig. 3c and d.
Urinary oligosaccharide analysis showed a similar pattern
to that of his brother. Final diagnosis of a-fucosidosis was
made based on undetectable enzyme activity of fucosidase in
his leukocytes.3. Discussion
Based on age of presentation and life expectancy two types of
a-fucosidosis; type I and type II have been described [5]. Type I
manifests around 6 months of age, is characterized by rapid
psychomotor regression and death within the first decade of
life. Type 2 presents with psychomotor regression between 12
Lane 1 Lane 2 Lane 3 Lane 4 Lane 5
Figure 4 One-dimensional TLC plate of urinary oligosaccha-
rides. Lane 1: dextran hydrolysates. Lane 2: standards of galactose
(upper) and raffinose (lower). Lane 3: fucosidosis-positive control
urine from ERNDIM. Lane 4: patient #1, Lane 5: patient #2.
246 R. Shaukat et al.and 24 months of life and has longer survival. However, a clear
clinical distinction between type I and II does not exist, but
they seem to be in a continuous clinical spectrum. Based on
the age of presentation we can classify our patients as a-
fucosidosis type II.
Both patients described here exhibited same severity and
course. The intra-familial variability in clinical presentation
reported previously [4,6] was not observed in this family.
The MRI brain findings; decreased white matter volume along
with low signals in thalami and substantia nigra on T2WI seen
in our patients were comparable to the classic features
described for a-fucosidosis [7].
The actual frequency of a-fucosidosis is unknown but is
expected to be underestimated due to difficulty in establishing
a definitive diagnosis especially in resource limited countries.
Thus a clinical approach aided by simple measures like ascer-
tainment of the presence or absence of dysostosis multiplex,coarse facies, cherry red spots and organomegaly aids in nar-
rowing the differential diagnosis of neurodegenerative disor-
ders to reach to the diagnosis of a-fucosidosis. Early
diagnosis of a-fucosidosis may alleviate the natural course of
the disease as clinical improvement has been reported in
human a-fucosidosis after hematopoietic stem cell transplanta-
tion HSCT [8].
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